Preparation, physical properties, and stability of gambogic acid-loaded micelles based on chitosan derivatives

Drug Development and Industrial Pharmacy

Volumn 34, Issue 1, 2008, Pages 2-9

  Zhu, Xian ^a   Zhang, Can ^a   Wu, Xiaoli ^a   Tang, Xiaoyan ^a   Ping, Qineng ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Chitosan micelles; Gambogic acid; Orthogonal experimental design; Preparation

Indexed keywords

ALCOHOL; CHITOSAN DERIVATIVE; GAMBOGIC ACID; N OCTYL O SULFATE CHITOSAN; UNCLASSIFIED DRUG; WATER;

ARTICLE; CALCULATION; COMPARATIVE STUDY; DIALYSIS; DRUG FORMULATION; DRUG SOLUBILITY; DRUG SOLUTION; DRUG STABILITY; EXPERIMENTAL DESIGN; FREEZE DRYING; PHYSICAL CHEMISTRY; QUANTITATIVE ANALYSIS; STORAGE TEMPERATURE; TEMPERATURE;

ANTINEOPLASTIC AGENTS; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; DRUG STABILITY; ETHANOL; MICELLES; PARTICLE SIZE; SOLUBILITY; TEMPERATURE; XANTHONES;

EID: 38549092978     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040701378001     Document Type: Article

References (31)

1. Aliabadi, H. M., & Lavasanifar, A. (2006). Polymeric micelles for drug delivery. Expert. Opin. Drug Deliv., 3, 139-162.
2. Allen, C., Maysinger, D., & Eisenberg, A. (1999). Nano-engineering block copolymer aggregates for drug delivery. Colloids Surf. B: Biointerfaces, 16, 3-27.
3. Asano, J., Chiba, K., Tada, M., & Yoshii, T. (1996). Cytotoxic xanthones from Garcinia hanburyi. Phytochemistry, 41, 815-820.
4. Dai, J. G. (2003). The preparation of a kind of gambogic acid injection. Chinese Patent. CN 03131511.9.
5. Feng, S. S., Mu, L., Chen, B. H., & Pack, D. (2002). Polymeric nanospheres fabricated with natural emulsifiers for clinical administration of an anticancer drug paclitaxel (Taxol®). Mater. Sci. Eng., 20, 85-92.
6. Fini, A., & Orienti, I. (2003). The role of chitosan in drug delivery. Am. J. Drug Deliv., 1, 43-59.
7. Han, Q. B., Cheung, S., Tai, J., Qiao, C. F., Song, J. Z., & Xu, H. X. (2005). Stability and cytotoxicity of gambogic acid and its derivative, gambogoic acid. Pharm. Bull., 28(12), 2335-2337.
8. Hao, K., Liu, X. Q., & Wang, G. J. (2005). Pharmacokinetics of gambogic acid in rats. J. China Pharm U., 36(4), 338-341.
9. Hassan, E. E., Parish, R. C., & Gallo, J. M. (1992). Optimized formulation of magnetic chitosan microspheres containing the anticancer agent, oxantrazole. Pharm. Res., 9(3), 390-397.
10. Jin, B., Dong, H., & Qiao, L. (2003). Chinese Patent. CN 02124510.X.
11. Kataoka, K., Harada, A., & Nagasaki, Y. (2001). Block copolymer micelles for drug delivery: Design, characterization, and biological significance. Adv. Drug Deliv. Rev., 47, 113-131.
12. Kataoka, K., Kwon, G. S., Yokoyama, M., Okano, T., & Sakurai, Y. (1993). Block copolymer micelles as vehicles for drug delivery. J. Controlled. Release, 24, 119-132.
13. Kwon, G. S., & Okano, T. (1996). Polymeric micelles as new drug carriers. Adv. Drug Deliv. Rev., 21, 107-116.
14. Lavasanifar, A., Sanuel, J., & Kwon, G. S. (2002). Poly(ethylene oxide)-blockpoly (L-amino acid) micelles for drug delivery. Adv. Drug Deliv. Rev., 54, 169-190.
15. Lin, L. J., Lin, L. Z., Pezzuto, J. M., Cordell, G. A., & Ruangrungsi, N. (1993). Isogambogic acid and isomorellinol from Garcinia hanburyi. Magn. Reson. Chem., 31, 340-347.
16. Lundberg, B. B., Risovic, V., & Ramaswamy, M. A. (2003). Lipophilic paclitaxel derivative incorporated in a lipid emulsion for parenteral administration. J. Contr. Release, 86, 93-100.
17. Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001). Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev., 53, 283-318.
18. Mu, L., & Feng, S. S. (2003). A novel controlled release formulation for the anticancer drug paclitaxel (Taxol®): PLGA nanoparticles containing vitamin E TPGS. J. Contr. Release, 86, 33-38.
19. Nishiyama, N., Bae, Y., Miyata, K., Fukushima, S., & Kataoka, K. (2005b). Smart polymeric micelles for gene and drug delivery. Drug Discov. Today Technol., 2, 21-26.
20. Nishiyama, N., & Kataoka, K. (2006). Nanostructured devices based on block copolymer assemblies for drug delivery: Designing structures for enhanced drug function. Adv. Polym. Sci., 193, 67-101.
21. Plessis, J., Ramachandran, C., Weiner, N., & Muller, D. G. (1996). The influence of lipid composition and lamellarity of liposomes on the physical stability of liposomes upon storage. Int. J. Pharm., 127, 273-278.
22. Riccardo, A. A., & Muzzarelli, C. (2005). Chitosan chemistry: Relevance to the biomedical sciences. Adv. Polym. Sci., 186, 151-209.
23. Sezgin, Z., Yuksel, N., & Baykara, T. (2006). Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs. Eur. J. Pharm. Biopharm., 64, 261-268.
24. Su, D. S., & Wang, S. L. (2004). Physical pharmaceutics. Chemical Industry Press: Beijing, China.
25. Torchilin, V. P. (2001). Structure and design of polymeric surfactant-based drug delivery systems. J. Control. Release, 73, 137-172.
26. Torchilin, V. P. (2002). PEG-based micelles as carriers of contrast agents for different imaging modalities. Adv. Drug Deliv. Rev., 54, 235-252.
27. Wu, Z. Q., Guo, Q. L., You, Q. D., Zhao, L., & Gu, H. Y. (2004). Gambogic acid inhibits proliferation of human lung carcinoma SPC-A1 cells in vivo and in vitro and represses telomerase activity and telomerase reverse transcriptase mRNA expression in the cells. Biol. Pharm. Bull., 27, 1769-1774.
28. You, Q. D., Guo, Q. L., Ke, X., Xiao, W., Dai, L. L., & Lin, Y. (2003). The preparations of gambogic acid and its compound. Chinese Patent. CN03132386.3.
29. Zhang, C., Ping, Q. N., & Zhang, H. J. (2004). Self-assembly and characterization of paclitaxel-loaded N-octyl-O-sulfate chitosan micellar system. Colloids Surf. B: Biointerfaces, 39, 69-75.
30. Zhang, C., Ping, Q. N., Zhang, H. G., & Shen, J. (2003). Preparation of N-alkyl-O-sulfate chitosan derivatives and micellar solubilization of taxol. Carbohydrate Polym., 54, 137-141.
31. Zimmermann, E., Muller, R. H., & Mader, K. (2000). Influence of different parameters on reconstitution of lyophilized SLN. Int. J. Pharm., 196(2), 211-213.